
Edward Messing
Winfield W. Scott Professor and Chairman · Henry Ford Health
Credentials: · · · ·
History
- Present

- Present

- 1972–1979

Research
The Journal of Urology · 2009 · 988 citations
New England Journal of Medicine · 1999 · First of 6 authors · Corresponding · 939 citations
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial
JAMA · 2006 · 745 citations

28 papers · 9 as a resident

21 papers · 5 as a resident

20 papers

19 papers

15 papers · 14 as a resident

15 papers
- JY
15 papers

13 papers
Grants
- 1994–2002
Markers of Bladder Cancer and Their Modulation by Dfmo
National Cancer Institute · U01
Contact PI · $843.2K · University of Rochester
- 1978–1998
Core Cancer Center Support Grant
National Cancer Institute · P30
Contact PI · $1.7M · University of Rochester
- 1990–1996
Selected Mechanisms of Bladder Carcinogenesis
National Cancer Institute · P01
Contact PI · $2.4M · University of Wisconsin-Madison
- 1987–1990
Epidermal Growth Factor and Human Bladder Cancer
National Cancer Institute · R01
Contact PI · $211.5K · University of Wisconsin-Madison
Clinical trials
- 2026–2028
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
Principal investigator · Recruiting · Phase 1
University of Wisconsin, Madison
- 2017–2018
Near Infrared Fluorescence Imaging for Bladder Cancer Detection
Principal investigator · Completed
Edward Messing
- 2016–2017
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Principal investigator · Terminated
University of Rochester
- 2016–2018
Enzalutamide for Bladder Cancer Chemoprevention
Principal investigator · Terminated · Phase 2
University of Rochester


